Corvus Pharmaceuticals In... (CRVS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

7.51

2.18%

After-hours Dec 13, 2024, 06:34 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14
Revenue	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	151.00K	367.00K	460.00K	632.00K	743.00K	847.00K	842.00K	594.00K	148.00K	-
Gross Profit	-151.00K	-367.00K	-460.00K	-632.00K	-743.00K	-847.00K	-842.00K	-594.00K	-148.00K	-
Operating Income	-23.33M	-32.56M	-38.63M	-43.76M	-48.85M	-49.22M	-56.52M	-36.98M	-13.77M	-175.64K
Interest Income	-	654.00	-	540.00K	2.18M	2.28M	861.00K	601.00K	35.00K	-
Pretax Income	-27.03M	-41.31M	-43.24M	-6.00M	-46.67M	-46.94M	-55.66M	-36.38M	-31.34M	-175.64K
Net Income	-27.03M	-50.05M	-38.20M	-4.82M	-43.75M	-46.94M	-55.66M	-36.38M	-31.34M	-175.64K
Selling & General & Admin	6.73M	8.10M	9.52M	11.93M	10.88M	10.64M	10.22M	7.62M	2.42M	134.18K
Research & Development	16.53M	24.47M	29.11M	31.83M	37.98M	38.59M	46.30M	29.36M	11.35M	41.45K
Other Expenses	-	587.00K	235.00K	37.46M	-	-	-	-	-17.60M	-
Operating Expenses	23.41M	32.56M	38.63M	43.76M	48.85M	49.22M	56.52M	36.98M	13.77M	175.64K
Interest Expense	1.58M	654.00K	15.00K	540.00K	2.18M	2.28M	-	601.00K	-	-
Selling & Marketing Expenses	-151.00K	-	-	-	-	-	-	-	-	-
Cost & Expenses	23.41M	32.56M	38.63M	43.76M	48.85M	49.22M	56.52M	36.98M	13.77M	175.64K
Income Tax	-	8.74M	-5.04M	-1.17M	-2.92M	2.28M	-842.00K	-594.00K	-35.00K	-
Shares Outstanding (Basic)	48.03M	46.55M	41.85M	29.48M	29.35M	27.51M	20.49M	15.42M	20.41M	170.00K
Shares Outstanding (Diluted)	48.03M	46.55M	41.85M	29.48M	29.35M	27.51M	20.49M	15.42M	20.41M	170.28K
EPS (Basic)	-0.56	-1.08	-0.91	-0.16	-1.49	-1.71	-2.72	-2.36	-1.54	-1.03
EPS (Diluted)	-0.56	-1.08	-0.91	-0.16	-1.49	-1.71	-2.72	-2.36	-1.54	-1.03
EBITDA	-26.88M	-40.94M	-42.78M	-5.36M	-48.85M	-46.09M	-54.82M	-35.78M	-31.19M	14.64K
Depreciation & Amortization	151.00K	367.00K	460.00K	632.00K	743.00K	847.00K	842.00K	594.00K	148.00K	175.64K